Mechanism of action and selection of endoscopic bariatric therapies for treatment of obesity

키워드

참고문헌 (72)

1. Busebee B, "Obesity : a review of patho physiology and classification", Mayo Clin Proc, 98, pp.1842~1857 (2023)
2. Wang Y, "Will all Americans become overweight or obese? : estimating the progression and cost of the US obesity epidemic", Obesity(Silver Spring), 16, pp.2323~2330 (2008)
3. Waters H, "America’s obesity crisis: the health and economic costs of excess weight" (2018), Milken Institute
4. Apovian CM, "Obesity : definition, comorbidities, causes, and burden", Am J Manag Care, 22(7 Suppl), pp.s176~s185 (2016)
5. Saunders KH, "Devices and endoscopic bar iatric therapies for obesity", Curr Obes Rep, 7, pp.162~171 (2018)
6. Gong EJ, "Small bowel endoscopic bariatric therapies", Clin Endosc, 51, pp.425~429 (2018)
7. Cho JH, "The clinical and metabolic effects of intragastric balloon on morbid obesity and its related comorbidities", Clin Endosc, 54, pp.9~16 (2021)
8. Gollisch KS, "Endoscopic intragastric balloon : a gimmick or a viable option for obesity?", Ann Transl Med, 8(Suppl 1), pp.S8~ (2020)
9. Carrano FM, "The role of minimally invasive and endoscopic technologies in morbid obesity treatment : review and critical appraisal of the current clinical practice", Obes Surg, 30, pp.736~752 (2020)
10. Doldi SB, "Treatment of morbid obesity with intragastric balloon in association with diet", Obes Surg, 12, pp.583~587 (2002)
11. Coffin B, "Impact of intragastric balloon before laparoscopic gastric bypass on patients with super obesity : a randomized multicenter study", Obes Surg, 27, pp.902~909 (2017)
12. Choudhary NS, "Intragastric balloon as a novel modality for weight loss in patients with cirrhosis and mor bid obesity awaiting liver transplantation", Indian J Gastroenterol, 35, pp.113~116 (2016)
13. Storm AC, "Intragastric balloon for management of morbid obesity in a candidate for heart transplanta tion", J Heart Lung Transplant, 36, pp.820~821 (2017)
14. Blundell JE, "Perspective on the central control of appetite", Obesity (Silver Spring), 14(Suppl 4), pp.160S~163S (2006)
15. Cifuentes L, "Gastric sensory and motor functions and energy intake in health and obesity-therapeutic impli cations", Nutrients, 13, pp.1158~ (2021)
16. Mion F, "Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients", Obes Surg, 15, pp.510~516 (2005)
17. Layec S, "Gastric tone, volume and emptying after implantation of an intragastric balloon for weight control", Neurogastroenterol Motil, 22, pp.1016~1021 (2010)
18. Abu Dayyeh BK, "Baseline gastric emptying and its change in response to diverse endoscopic bariatric therapies predict weight change after intervention", Gastroenterology, 150, pp.S86~S86 (2016)
19. Su HJ, "Effect of intragastric balloon on gastric emptying time in humans for weight control", Clin Nucl Med, 38, pp.863~868 (2013)
20. Gómez V, "Delayed gastric empty ing as a proposed mechanism of action during intragastric balloon therapy : results of a prospective study", Obesity(Silver Spring), 24, pp.1849~1853 (2016)
21. Genco A, "BioEnterics intragastric balloon : the Italian experience with 2, 515 patients", Obes Surg, 15, pp.11611164~ (2005)
22. McCarty TR, "The current state of bariatric endosco py", Dig Endosc, 33, pp.321~334 (2021)
23. Abu Dayyeh BK, "Adjustable intragastric balloon for treatment of obesity : a multicentre, open-label, ran domised clinical trial", Lancet, 398, pp.1965~1973 (2021)
24. Popov VB, "The impact of intragastric balloons on obesity-related co-morbidities : a systematic review and meta-analysis", Am J Gastroenterol, 112, pp.429~439 (2017)
25. Shahnazarian V, "Endoscopic bariatric therapies for treating obesity : a learning curve for gastroenterologists", Transl Gastroenterol Hepatol, 4, pp.16~ (2019)
26. Abu Dayyeh BK, "Endoscopic sleeve gastroplas ty : a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity", Gastrointest Endosc, 78, pp.530~535 (2013)
27. Lopez-Nava G, "Endoscopic sleeve gastroplasty : how I do it?", Obes Surg, 25, pp.1534~1538 (2015)
28. Espinós JC, "Gastrointestinal physiological changes and their relationship to weight loss following the POSE procedure", Obes Surg, 26, pp.1081~1089 (2016)
29. Gys B, "Endoscopic gastric plication for morbid obesity : a systematic review and meta-analysis of published data over time", Obes Surg, 29, pp.3021~3029 (2019)
30. Kumar N, "Endoscop ic sutured gastroplasty : procedure evolution from first-in-man cases through current technique", Surg Endosc, 32, pp.2159~2164 (2018)
31. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals", Clin Gastroenterol Hepatol, 15, pp.37~43 (2017)
32. Vargas EJ, "Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones : a compar ative prospective study", Gut, 72, pp.1073~1080 (2023)
33. Lopez-Nava G, "Prospective com parison of fluid-filled intragastric balloon and endoscopic gastro plasty on physiologic measures of appetite : insights into mechanism of action and personalization of procedure choice", Gastrointest En dosc, 89, pp.AB61~ (2019)
34. Hedjoudje A, "Efficacy and safety of endoscopic sleeve gastroplasty : a systematic review and me ta-analysis", Clin Gastroenterol Hepatol, 18, pp.1043~1053 (2020)
35. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity(MERIT) : a pro spective, multicentre, randomised trial", Lancet, 400, pp.441~451 (2022)
36. Alqahtani A, "Short-term out comes of endoscopic sleeve gastroplasty in 1000 consecutive pa tients", Gastrointest Endosc, 89, pp.1132~1138 (2019)
37. Maselli DB, "Endoscopic gastric suturing for weight loss : techniques and outcomes", Tech Innov Gastrointest Endosc, 22, pp.136~144 (2020)
38. Khan Z, "Efficacy of endoscopic interventions for the management of obesity : a meta-analysis to compare endoscopic sleeve gastroplasty, AspireAssist, and primary obesity surgery endolumenal", Obes Surg, 29, pp.2287~2298 (2019)
39. Lopez Nava G, "Prospective multi center study of the primary obesity surgery endoluminal(POSE 2. 0)procedure for treatment of obesity", Clin Gastroenterol Hepatol, 21, pp.81~89 (2023)
40. Norén E, "Aspiration therapy for obesity; a safe and effec tive treatment", BMC Obes, 3, pp.56~ (2016)
41. Sullivan S, "Aspiration therapy for obesity", Gastrointest Endosc Clin N Am, 27, pp.277~288 (2017)
42. "Summary of safety and effectiveness data: AspireAssist" (2016)[URL]
43. Zhu Y, "Increasing the number of chews before swallowing reduces meal size in normal-weight, overweight, and obese adults", J Acad Nutr Diet, 114, pp.926~931 (2014)
44. Hollis JH, "The effect of mastication on food intake, satiety and body weight", Physiol Behav, 193(Pt B), pp.242~245 (2018)
45. Sullivan S, "Aspiration therapy leads to weight loss in obese subjects : a pilot study", Gastroenterology, 145, pp.1245~1252 (2013)
46. Thompson CC, "Aspiration therapy for the treatment of obesity : 4-year results of a multicenter random ized controlled trial", Surg Obes Relat Dis, 15, pp.1348~1354 (2019)
47. Thompson CC, "Percutaneous gastrostomy device for the treatment of class II and class III obe sity : results of a randomized controlled trial", Am J Gastroenterol, 112, pp.447~457 (2017)
48. Nyström M, "Aspiration therapy as a tool to treat obesity : 1-to 4-year results in a 201-patient multi-center post-market European registry study", Obes Surg, 28, pp.1860~1868 (2018)
49. Ruban A, "The EndoBarrier : duodenal-jejunal bypass liner for diabetes and weight loss", Gastroenterol Res Pract, 2018, pp.7823182~ (2018)
50. de Jonge C, "Endoscopic duodenal-je junal bypass liner rapidly improves type 2 diabetes", Obes Surg, 23, pp.1354~1360 (2013)
51. Patti ME, "Serum bile acids are higher in humans with prior gastric bypass : potential contribution to im proved glucose and lipid metabolism", Obesity(Silver Spring), 17, pp.1671~1677 (2009)
52. Penney NC, "The role of bile acids in re ducing the metabolic complications of obesity after bariatric surgery : a systematic review", Int J Obes(Lond), 39, pp.1565~1574 (2015)
53. Betzel B, "Weight reduction and improve ment in diabetes by the duodenal-jejunal bypass liner : a 198 patient cohort study", Surg Endosc, 31, pp.2881~2891 (2017)
54. Yvamoto EY, "The effectiveness and safety of the duodenal-jejunal bypass liner(DJBL)for the manage ment of obesity and glycaemic control : a systematic review and me ta-analysis of randomized controlled trials", Obes Surg, 33, pp.585599~ (2023)
55. Forner PM, "Safety and effectiveness of an endoscopically placed duodenal-jejunal bypass device(EndoBar rier®) : outcomes in 114 patients", Obes Surg, 27, pp.3306~3313 (2017)
56. Quezada N, "Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years", Surg Endosc, 32, pp.260~267 (2018)
57. Cherrington AD, "Hydrothermal duodenal mucosal resurfacing : role in the treatment of metabolic disease", Gastrointest Endosc Clin N Am, 27, pp.299~311 (2017)
58. Rajagopalan H, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes : 6-month interim analysis from the first-in-human proof-of-concept study", Diabetes Care, 39, pp.2254~2261 (2016)
59. Telese A, "Bariatric and metabolic endos copy : a new paradigm", Clin Transl Gastroenterol, 12, pp.e00364~ (2021)
60. van Baar AC, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus : one year results from the first international, open-label, prospective, multicentre study", Gut, 69, pp.295~303 (2020)
61. Zervos EE, "Amelioration of insulin re quirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes", J Am Coll Surg, 210, pp.564~572 (2010)
62. Rubino F, "The mechanism of dia betes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes", Ann Surg, 244, pp.741~759 (2006)
63. Machytka E, "Partial jejunal diversion using an incisionless magnetic anastomosis system : 1-year interim results in patients with obesity and diabetes", GastrointestEndosc, 86, pp.904912~ (2017)
64. Mehta A, "Bariatric and metabolic endoscopy : impact on obesity and related comorbidities", Ther Adv Gastrointest Endosc, 14, pp.26317745211019156~ (2021)
65. Camilleri M, "Peripheral mechanisms in appetite regulation", Gastro enterology, 148, pp.1219~1233 (2015)
66. Ghusn W, "Association between food intake and gastrointestinal symptoms in patients with obesity", Gastro Hep Adv, 2, pp.121~128 (2023)
67. Acosta A, "Selection of antiobesity medications based on phenotypes enhances weight loss : a pragmatic trial in an obesity clinic", Obesity(Silver Spring), 29, pp.662~671 (2021)
68. Acosta A, "Exenatide in obesity with ac celerated gastric emptying : a randomized, pharmacodynamics study", Physiol Rep, 3, pp.e12610~ (2015)
69. Halawi H, "Effects of liraglutide on weight, satiation, and gastric functions in obesity : a randomised, placebo-controlled pilot trial", Lancet Gastroenterol Hepatol, 2, pp.890~899 (2017)
70. Acosta A, "Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy", Gastroenterology, 148, pp.537~546 (2015)
71. Vargas EJ, "Changes in time of gastric emptying after surgical and endoscopic bariatrics and weight loss : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 18, pp.57~68 (2020)
72. Rapaka B, "Effects on physiologic measures of appetite from intragastric balloon and endoscopic sleeve gastroplasty : results of a prospective study", Chin Med J(Engl), 135, pp.1234~1241 (2022)